年内，不少基金在净值上升的过程中戛然而止官宣清盘，且当前亦有重仓势头正好的医药板块的基金也公 告可能触发基金合同终止情形。 与市场"挥手作别"的主要原因系这些发起式基金在成立三年后在"规模大考"面前闯关失败，即使绩优产品也难 逃清盘。 从此前逆袭成功的相关产品来看，良好的业绩是发起式产品摆脱清盘之困甚至成长为百亿规模基金的必要因 素，此外，还需要渠道、宣发等一系列资源的大力支持，天时地利人和，才有机会在规模上快速提升。 多只发起式基金倒在黎明前 截至6月15日，在震荡走高的背景下，上半年的行情由以泡泡玛特、老铺黄金为代表的"新消费"和创新药板块 为主导，相关主题基金亦取得不俗涨幅。 然而，部分基金在持仓方面，却在净值向上势头良好之际倒在了黎明前。 以华安创新医药锐选量化为例，截至去年末，该基金前十大重仓股中包括了恒瑞医药、泽璟制药、药明生物、 百济神州等年内涨幅可观的个股，因此截至4月1日，年内净值涨幅高达22%，然而上涨势头却在一季度末戛然 而止，作为一只发起式基金，截至3月31日该产品整体规模仅剩1100万元，离"三年大考"的2亿元门槛相距甚 远，因此不得不选择清盘。 类似情况还有金鹰品质消费，该基金截至 ...

Market Performance - On June 16, A-shares saw all three major indices close higher, with over 3,500 stocks rising, including 75 stocks hitting the daily limit up [1] - The IT services sector led the gains, particularly driven by digital currency concepts, with Tianyang Technology and Sifang Jingchuang hitting the limit up [1] - Other notable sectors included oil and gas, IP economy, and various subfields like Ant Financial concepts and electronic identification [1] Historical Highs - A total of 31 stocks reached historical closing highs, with banks, basic chemicals, and electric equipment industries showing significant concentration, each having 7, 7, and 3 stocks respectively [3] - The average increase for stocks hitting historical highs was 5.69%, with notable performers including Sifang Jingchuang and Zhongdian Electric [3][4] Institutional Ratings - 13 stocks received buy ratings from institutions, with Dongshan Precision receiving the highest attention with three buy ratings [5][6] - The average increase for stocks with buy ratings was 2.02%, outperforming the Shanghai Composite Index, with Dongshan Precision and others showing significant gains [6] Institutional Net Buying and Selling - 13 stocks saw net buying exceeding 10 million yuan from institutions, with Yuekang Pharmaceutical leading at 227 million yuan [8][9] - In contrast, Yibin Technology faced the highest net selling at 27.16 million yuan, followed by Aoyang Health and Tianyang Technology [8][9] Northbound Capital Flow - 11 stocks received net buying from northbound funds, with Guangxi Media leading at 210 million yuan [10][11] - Conversely, Qianhong Pharmaceutical experienced the highest net selling at 73.73 million yuan [10][11] Corporate Announcements - Bangji Technology plans to acquire shares in several agricultural companies, shifting its focus from pig feed to integrated pig farming [12] - CITIC Construction received approval to issue up to 6 billion yuan in technology innovation bonds to support investments in the tech sector [12]

1.两市主力资金净流出超27亿元 今日沪深两市主力资金开盘净流出36.84亿元，尾盘净流入0.57亿元，两市全天主力资金净流出27.3亿元。 盘后数据出炉。 6月16日，A股市场整体上涨。截至收盘，上证指数报3388.73点，上涨0.35%；深证成指报10163.55点，上涨0.41%；创业板指 报2057.32点，上涨0.66%。两市合计成交12150.76亿元，较上一交易日减少2521.22亿元。 沪深300今日主力资金净流入8.58亿元，创业板净流入0.25亿元。 | | | 各板块最近五个交易日主力资金净流入数据(亿元) | | | --- | --- | --- | --- | | 日期 | 沪深300 | 创业板 | 科创板 | | 2025-6-16 | 8. 58 | 0. 25 | -1. 43 | | 2025-6-13 | -79.36 | -170.92 | 0. 67 | | 2025-6-12 | 3.96 | -33.04 | -7.48 | | 2025-6-11 | -3.46 | -25.13 | 11. 72 | | 2025-6-10 | -60. 60 | -168. ...

Core Viewpoint - The recent trend of leading A-share companies listing on H-shares is gaining momentum, with several companies successfully completing their listings in Hong Kong, enhancing their international market presence and brand recognition [1][2]. Group 1: H-share Listing Trend - Leading companies like Midea Group, CATL, and Heng Rui Pharmaceutical have recently listed on the Hong Kong Stock Exchange, indicating a growing trend among A-share companies to seek H-share listings [1]. - Stone Technology announced its intention to list on the Hong Kong Stock Exchange, further contributing to the ongoing "H-share boom" [2]. Group 2: Investment Considerations - Investors face a dilemma regarding whether to invest in A-shares or H-shares of companies listed on both exchanges, as each market has distinct advantages and disadvantages [2]. - Analysts highlight that H-shares generally trade at a discount compared to A-shares due to differences in investor structure, liquidity, and refinancing mechanisms [3][5]. Group 3: Price Discrepancies - The long-term price discrepancy between A-shares and H-shares is attributed to the lack of free convertibility and arbitrage mechanisms between the two markets [3]. - Currently, only 155 companies are listed on both A and H-shares, representing a small fraction of the total number of companies on the Hong Kong main board [5][6]. Group 4: Sector Analysis - The majority of companies listed on both exchanges are state-owned enterprises and belong to traditional economic sectors, such as finance and energy, which tend to attract dividend-focused investors [6]. - The analysis suggests that the price differences between A and H-shares can be better understood through a dividend perspective rather than purely market sentiment [6]. Group 5: Recent Market Dynamics - The phenomenon of "A-H share price inversion" has been observed, particularly with companies like CATL, where H-shares traded at a premium to A-shares, indicating a shift in market dynamics [7][9]. - The current macroeconomic environment and differing investor preferences contribute to the observed price behaviors between A and H-shares [9][10]. Group 6: Future Outlook - Companies like Stone Technology, which have a significant portion of their revenue from overseas markets, are expected to attract foreign investment and may experience similar price dynamics as seen with CATL [12][13]. - The ongoing trend of high dividend yields in the Hong Kong market, coupled with structural opportunities in sectors like new consumption and technology, positions H-shares favorably for investors [16][17].

融资资金流入扩大,外资流入中国资产 -- 投资者微观行为洞察手册 · 6月第2 期 本报告导读: 本期市场交易热度持续抬升,资金行为分化。外资转为流入,融资资金流入规模扩 大,而 ETF 资金流出,偏股基金新发行规模下降。此外南下资金流入边际抬升。 投资要点: 市场定价状态:市场整体交易热度大幅上升,行业轮动强度下降。 1)市场情绪(上升):本期国泰海通资金流入强度指数整体持续下 降,市场交易热度大幅上升,全 A日均成交额从 1.2 万亿升至 1.4 万亿,上证指数换手率分位数抬升至 82%,科创板换手率分位数抬 升至 52%。日均涨停家数下降至 66家,最大连板数为 7个,封板率 策略研究 / 2025.06.16 方奕(分析师) 021-38676666 登记编号 S0880520120005 郭胤含(分析师) 021-38676666 管记编与 S0880524100001 田开轩(分析师) 021-38676666 分汇编号 S0880524080006 维持 71%,龙虎榜上榜家教降至 33家。2）赚钱效应(下降):本 期个股收涨比例下降至 34%,全 A 个股周度收益中位数下降至- 1.3%;3) ...

分析师：孟之绪 执业编号：S0300524080001 电话： 邮箱：mengzhixu@ykzq.com 投资策略研究 证券研究报告 | 策略点评 2025 年 06 月 16 日 投资要点 粤开市场日报-20250616 今日关注 | 一、市场回顾 | 3 | | --- | --- | | 二、风险提示 | 3 | 今日主要指数涨跌幅：沪指涨跌幅为 0.35%，深证成指涨跌幅为 0.41%， 创业板指涨跌幅为 0.66%。 申万一级行业表现：传媒、通信、计算机在行业涨跌幅榜居前；纺织服 饰、医药生物、汽车在行业涨跌幅榜居后。 概念板块表现：总体来看，数字货币、金融科技、首板概念表现相对较 好；黄金珠宝、仿制药、化学纤维概念表现相对较差。 风险提示 股市有风险，投资需谨慎。 请务必阅读最后特别声明与免责条款 www.ykzq.com 1 / 5 | 图表 1： | | --- | | 今日主要指数涨跌幅（%）及概念板块表现 3 | 策略点评 一、市场回顾 图表1：今日主要指数涨跌幅（%）及概念板块表现 二、风险提示 股市有风险，投资需谨慎 请务必阅读最后特别声明与免责条款 www.ykzq.com 3 / ...

[Table_Main] 行业研究|医疗保健 证券研究报告 医疗保健行业周报 2025 年 06 月 16 日 [Table_Title] 药品、耗材集采有望优化，建议关注集采出清板块 ——医药生物行业周报（2025.6.9-2025.6.13） [Table_Summary] 报告要点： 医药板块本周小幅跑赢沪深 300 指数 2025 年 6 月 9 日至 6 月 13 日，申万医药生物指数上涨 1.40%，跑赢 沪深 300 指数 1.65pct，在 31 个申万一级行业指数中排名第 5。2025 年初至今，申万医药生物指数上涨 9.33%，跑赢沪深 300 指数 11.13pct，涨跌幅在 31 个申万一级行业指数中排名第 4。截至 2025 年 6 月 13 日，医药板块估值为 28.29 倍（TTM 整体法，剔除负值）， 相对于沪深 300 估值溢价率为 153.19%。 本周易明医药、赛升药业和澳洋健康等表现较好 涨幅排名前十的个股分别为：易明医药（+38.49%）、赛升药业 （+36.35%）、澳洋健康（+35.01%）、昂利康（+34.30%）、康惠制药 （+30.93%）、百洋医药（+28 ...

申万宏源策略 . 我们强调体系性、实战性 一、区域冲突再升级，触发全球风险偏好下行，A股顺势休整。这背后，区域冲突可能只是脉 冲式影响，短期休整的核心，还是结构性行情已演绎至低性价比区域，市场内在稳定性下降。 我们继续提示，稳定资本市场政策为A股提供了对宏观扰动的"隔离墙"。判断中短期市场，可 适当降低宏观分析权重，提升强势板块节奏判断的权重。 本周，区域冲突再升级，触发全球风险偏好下行。A股休整是全球股市普跌的一部分。目前的 冲突，对中美广泛竞争的格局，尚不会产生方向性影响。那么，区域冲突对资产价格的影响， 主要体现为直接影响风险偏好，以及通过油价和通胀预期扰动资产配置环境，且大概率是脉冲 式影响。 以下文章来源于申万宏源策略 ，作者申万宏源策略 三、新消费(珠宝钻石、IP潮玩、新零食新饮品、美妆个护)和创新药龙头仍在景气叙事中。短 期高位波动加剧，但不是中级别风险，基本面趋势投资高举高打仍能维持。短期海外扰动增 加，油气和贵金属是对冲资产。继续提示，港股是潜在牛市中的领涨市场。 短期海外扰动增加，贵金属和油气出现脉冲式修复。我们继续提示，新消费(珠宝钻石、IP潮 玩、新零食新饮品、美妆个护)和创新药龙头本 ...

| 300773 | 拉卡拉 | 0.94 | 8871.09 | 115024.20 | 6.62 | 非银金 | | --- | --- | --- | --- | --- | --- | --- | | | | | | | | 融 | | 688166 | 博瑞医 | -2.50 | 8850.60 | 137767.47 | 5.76 | 医药生 | | | 药 | | | | | 物 | | 002556 | 辉隆股 | -10.04 | 8836.31 | 46851.78 | 7.46 | 农林牧 | | | 份 | | | | | 渔 | | 601288 | 农业银 行 | -0.53 | 8559.16 | 172549.93 | 0.10 | 银行 | | 600259 | 广晟有 | 6.00 | 8477.72 | 80988.73 | 4.31 | 有色金 | | | 色 | | | | | 属 | | 002384 | 东山精 密 | -1.63 | 8243.41 | 434568.27 | 9.97 | 电子 | | 601166 | 兴业银 | -1.51 | 7949.5 ...

北交所策略专题报告 2025 年 06 月 15 日 北交所打新策略：募资规模提升，中签率迎来改善窗口 北交所研究团队 ——北交所策略专题报告 诸海滨（分析师） zhuhaibin@kysec.cn 证书编号：S0790522080007 专题：2025 年 Q2 北交所过会提速，募资规模提高或改善中签率 从发审会节奏上来看，截至 2025 年 6 月 13 日，2025 年 1-6 月北交所合计过会 9 家企业，2025 年 2 季度开始，随着申报企业补充 2024 年报数据的结束，北交所 上市节奏或提升。北交所打新高热度，从 2024 年三季度末开始，随着北交所市 场逐步活跃，2025 年 1-6 月北交所网上发行有效申购户数均值达 46.01 万户，网 上冻结资金均值达 4752 亿元。募资规模提高或改善中签率，2024 年-2025 年 6 月 13 日期间北交所合计上市 28 家企业，中签率均值达 0.09%，其中首发募集资 金超过 2 个亿企业的平均中签率在 0.14%，首发募集低于 2 个亿企业的平均中签 率在 0.06%。募资规模方面，2025 年 1-6 月北交所单家企业平均募集资金达 3. ...